CTNM
Contineum Therapeutics
CTNM
CTNM
90 hedge funds and large institutions have $399M invested in Contineum Therapeutics in 2026 Q1 according to their latest regulatory filings, with 22 funds opening new positions, 29 increasing their positions, 21 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
34.64% less ownership
Funds ownership: 128.15% → 93.52% (-35%)
Holders
90
Holding in Top 10
4
Calls
$148K
Puts
–
Top Buyers
| 1 | +$9.45M | |
| 2 | +$7.04M | |
| 3 | +$4.7M | |
| 4 |
Janus Henderson Group
London,
United Kingdom
|
+$3.83M |
| 5 |
LP
Longaeva Partners
Chicago,
Illinois
|
+$3.52M |
Top Sellers
| 1 | -$11.9M | |
| 2 | -$9.33M | |
| 3 | -$9.04M | |
| 4 |
PA
Perceptive Advisors
New York
|
-$2.8M |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
-$2.4M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
101
Group One Trading
Chicago,
Illinois
| – |
|